What are the differences between Ozempic, Wegovy, and Zepbound?

Key Takeaways: 

Ozempic and Wegovy both contain semaglutide but are FDA-approved for different purposes and prescribed at various doses, while Zepbound contains tirzepatide, a dual-action medication that targets two hormone receptors instead of one. None of these medications is universally best—the appropriate choice depends on your prior health history, goals, existing conditions, and response to treatment. In our in-depth evaluation, we’ll determine whether a GLP-1 medication may be appropriate and, if so, which one makes the most clinical sense.

The names have become part of everyday conversation—you've heard them from friends, seen them in headlines, and probably searched for them more than once. Ozempic, Wegovy, and Zepbound are among the most talked-about medications in medicine right now, and the interest is understandable: these GLP-1s represent a meaningful shift in how obesity and metabolic health are treated.

But familiarity with a brand name is different from understanding what a medication actually does, who it's approved for, and whether it might be appropriate for you.

The care team at Core Medicine of Idaho Family Practice and Urgent Care in Caldwell works with patients throughout Canyon County who are exploring medical weight loss options and better chronic condition management. Clear information is the foundation of those conversations. 

Here’s a straightforward comparison of the three medications so you and your provider can decide which is right for you.

What Are the Active Ingredients in Each Medication?

Although Ozempic, Wegovy, and Zepbound are often discussed together, they don’t all contain identical medications or work in exactly the same way. Knowing more about their active ingredients helps explain the differences in how they’re prescribed, what they’re approved to treat, and how they may affect your body.

Ozempic and Wegovy Both Contain Semaglutide

Ozempic and Wegovy are brand-name medications produced by Noro Nordisk that contain the same active ingredient: semaglutide. Semaglutide is a GLP-1 receptor agonist that increases insulin secretion and reduces glucagon secretion when blood glucose is elevated. It also delays gastric emptying and affects appetite regulation, which can help patients feel fuller and consume fewer calories.

Although they contain the same active ingredient, Ozempic and Wegovy aren’t interchangeable. They are separate FDA-approved products with different indications, available doses, titration or dose-adjusting schedules, and prescribing instructions. Patients should not substitute one for the other without guidance from the prescribing clinician.

Zepbound Contains Tirzepatide

Zepbound, manufactured by Eli Lilly, contains tirzepatide, a dual GIP and GLP-1 receptor agonist. GIP and GLP-1 are incretin hormones involved in glucose-dependent insulin secretion and other processes that affect appetite and energy intake.

Because tirzepatide acts on two receptor pathways, its mechanism differs from that of semaglutide. Some patients may experience substantial appetite and weight changes with tirzepatide, but results vary, and the medication’s dual action doesn’t automatically make it the right choice for every patient. When choosing the right GLP-1 weight-loss medication, our providers at Core Medicine of Idaho consider not only your health history but also your treatment goals, potential risks, and response to therapy.

What Is Each Medication FDA-Approved to Treat?

Approval status matters significantly—both for clinical appropriateness and for insurance coverage.

Ozempic

Ozempic is primarily prescribed for adults with type 2 diabetes. It’s FDA-approved to improve blood sugar control and, in certain patients, to reduce cardiovascular and kidney-related risks associated with type 2 diabetes. Although many patients lose weight while taking Ozempic, it’s not FDA-approved specifically for chronic weight management. Prescribing it for weight loss in someone without type 2 diabetes would generally be considered off-label use.

Wegovy

Wegovy is FDA-approved for long-term weight reduction and maintenance in adults with an initial BMI of 30 or higher, or 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, or type 2 diabetes. The Wegovy injection and pill dosage contain semaglutide at a higher maximum approved maintenance dose than the Ozempic injection and are specifically labeled for weight management in eligible patients. Wegovy also has additional FDA-approved uses for certain patients, including reducing cardiovascular risk.

Zepbound

Zepbound is FDA-approved for long-term weight reduction and maintenance in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition. It’s also approved to treat moderate to severe obstructive sleep apnea in adults with obesity. A separate tirzepatide product, Mounjaro, is approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes. This is similar to the distinction between Ozempic and Wegovy, which contain the same active ingredient but have different approved uses.

What’s the Difference Between Ozempic, Wegovy, and Zepbound Regarding Dosing and Administration?

The injectable forms are administered under the skin once weekly, usually in the abdomen, thigh, or upper arm. However, the medications differ in their available dosage forms, strengths, titration schedules, and maintenance doses. Wegovy is also available as a once-daily oral tablet, so patients should follow the instructions for the specific product they have been prescribed. Generally: 

• Treatment starts at a low dose. This helps your body adjust to the medication.
• The dose increases gradually. Patients typically remain at each dose level for at least four weeks before moving to the next.
• Gradual increases may reduce side effects. Titration is intended to improve tolerability, particularly gastrointestinal symptoms.
• Results develop over time. Many people may notice changes before reaching a maintenance dose, with their response continuing to evolve.
• Follow-up guides dosing decisions. The prescribing provider can monitor progress, assess side effects, and adjust the dose when appropriate.

Are There Common Side Effects?

Yes. The profiles of semaglutide-based and tirzepatide-based medications overlap considerably, given their shared mechanism. The most commonly reported side effects are gastrointestinal:

• Nausea, particularly during dose increases
• Vomiting
• Diarrhea or constipation
• Reduced appetite that may be more pronounced than expected

These side effects often improve as your body adjusts to the medication. Serious but less common risks—including pancreatitis, gallbladder issues, and, in patients with a personal or family history of certain thyroid cancers, a potential thyroid risk flagged in prescribing information—are discussed during your evaluation with our Caldwell medical team before treatment begins. Anyone considering these medications should review their full medical history with a licensed clinician, not just a checklist.

Does Insurance Cover These Medications?

If you qualify for GLP-1 medication as part of your wellness plan, coverage varies significantly by insurance policy, employer, and specific medication. Wegovy and Zepbound are more commonly covered under plans with obesity treatment benefits, while Ozempic's coverage is typically tied to a diabetes diagnosis. 

Prior authorization requirements, step therapy protocols, and formulary placement vary by plan, and coverage situations change as insurers revise their policies. Our team at Core Medicine of Idaho can provide guidance on the insurance authorization process during your consultation.

Which Medication May Be Right for You?

There’s no single treatment that's right for everyone. The National Institute of Diabetes and Digestive and Kidney Diseases’ resource on obesity medications offers a helpful overview of how these drugs are categorized and evaluated. However, choosing a medication requires an individual assessment by a licensed provider rather than relying on general descriptions alone.

At Core Medicine of Idaho, we review your health history, goals, medication response, and changing needs over time. This individualized approach allows your care team to adjust treatment as needed and support sustainable weight reduction and chronic disease management.